SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.

导出 OA

翻译打印收藏纠错

作者： Xun,Shangguan ^[1] ; Jianli,He ^[1] ; Zehua,Ma ^[2] ; Weiwei,Zhang ^[1] ; Yiyi,Ji ^[1] ; Kai,Shen ^[1] ; Zhiying,Yue ^[1] ; Wenyu,Li ^[1] ; Zhixiang,Xin ^[1] ; Quan,Zheng ^[1] ; Ying,Cao ^[2] ; Jiahua,Pan ^[2] ; Baijun,Dong ^[1] ; Jinke,Cheng ^[1] ; Qi,Wang ^[3] ; Wei,Xue ^[4]

作者单位： State Key Laboratory of Oncogenes and Related Genes, Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. ^[1] Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[2] State Key Laboratory of Oncogenes and Related Genes, Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jkcheng@shsmu.edu.cn. ^[3] Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jkcheng@shsmu.edu.cn. ^[4] State Key Laboratory of Oncogenes and Related Genes, Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. wqi@sjtu.edu.cn. ^[5] State Key Laboratory of Oncogenes and Related Genes, Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. xuewei@renji.com. ^[6]